Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
Radiology|January 8, 2020
Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human GliomasXianqi Li, Bernhard Strasser, Kourosh Jafari-Khouzani, et al.
Cancer Discovery|July 2, 2020
Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor CellsHiroaki Nagashima, Christine K Lee, Kensuke Tateishi, et al.
Neuro-Oncology|February 18, 2020
"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomasRajan Jain, Derek R Johnson, Sohil H Patel, et al.
Neuro-Oncology Advances|August 1, 2022
Deep learning super-resolution magnetic resonance spectroscopic imaging of brain metabolism and mutant isocitrate dehydrogenase gliomaXianqi Li, Bernhard Strasser, Ulf Neuberger, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 23, 2021
Intraoperative thalamocortical tract monitoring via direct cortical recordings during craniotomyMirela V Simon, William T Curry, Pamela S Jones, et al.
Neuro-Oncology|January 23, 2019
Accelerated progression of IDH mutant glioma after first recurrenceJulie J Miller, Franziska Loebel, Tareq A Juratli, et al.
Journal of Neurosurgery. Case Lessons|February 26, 2024
Fluorescence and immune-cell infiltration of nonneoplastic, postbrachytherapy brain tissue in 5-ALA-guided resection of recurrent anaplastic meningioma: illustrative caseRishab Ramapriyan, Victoria E Clark, Maria Martinez-Lage, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2021
Evidence-based recommendations on categories for extent of resection in diffuse gliomaPhilipp Karschnia, Michael A Vogelbaum, Martin van den Bent, et al.
Cancer Research|October 1, 2020
Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in GlioblastomaMing Li, Ameya R Kirtane, Juri Kiyokawa, et al.
Journal of Neuro-Oncology|November 5, 2015
The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guidelineDaniel P Cahill, Andrew E Sloan, Brian V Nahed, et al.
Pageof 22